ArchiMed acquires neurodiagnostic devices provider Natus Medical
Natus shareholders received $33.50 in cash for each share of company common stock.
Business & Regulation
Latest in
Business & Regulation
Magazine: A choppy history of racial bias in oximetry
In this issue: Covid-19 has put bias in oximetry back in the spotlight, DCTs are helping break down barriers in…
By
Medtronic’s revenue increases 5% to $31.69bn in FY22
The company’s fourth quarter worldwide revenue declined by 1% on a reported basis to $8.09bn.
FDA identifies Avanos Medical’s Cortrak* 2 EAS recall as Class I
Avanos Medical recalled Cortrak* 2 EAS following reports of injuries and patient deaths due to tube misplacements.
Medtronic concludes Intersect ENT acquisition
The deal adds Intersect ENT's PROPEL and SINUVA sinus implant product lines and technology to Medtronic's portfolio.
Cepheid secures FDA EUA for rapid Covid-19 diagnostic test
Xpert Xpress CoV-2 plus is a rapid molecular diagnostic test designed to identify Covid-19 causing virus.
BD reports 2.1% increase in Q1 2022 revenues
The company’s net income in the quarter jumped 51.7% Y-o-Y to $454m.
Quidel’s quarterly revenues more than double to $1bn in Q1 2022
In the same quarter a year ago, the company reported revenues of $375.3m.